✦ LIBER ✦

180 EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL

✍ Scribed by Saliba, F.; Metselaar, H.J.; Beckebaum, S.; Duvoux, C.; Navasa, M.; Dong, G.; Lopez, P.; Nevens, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

26 EVEROLIMUS-BASED IMMUNOSUPPRESSION PR

✍ Nevens, F.; De Carlis, L.; Metselaar, H.J.; Kaiser, G.M.; Saliba, F.; Jonas, S.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

1402 EVEROLIMUS WITH EARLY REDUCTION OR

✍ Nevens, F.; De Carlis, L.; Metselaar, H.; Saliba, F.; Beckebaum, S.; Jonas, S.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 147 KB

24-month safety results of a randomized,

✍ H Eisen; J Kobashigawa; R.C Starling; N Cretin; J.S Jaffe; J Murphy 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 74 KB

15: Results of a 12-Month, Multicenter,

✍ H. Lehmkuhl; U. Livi; J. Arizon; M. Viganò; C. Magelli; P. Boissonnat; G. Gerosa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Efficacy and safety of de novo or early

✍ Jacques Dantal; François Berthoux; Marie-Christine Moal; Lionel Rostaing; Christ 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 335 KB